GLP-1s

Subscriber-Only eBook | Bio Precision Aging This guide is for educational purposes only and does not constitute medical advice. All treatment decisions should be made in consultation with a qualified healthcare professional. Executive Summary GLP-1 receptor agonists were originally developed to treat type 2 diabetes and obesity. Over the past several years, however, large human datasets have revealed something unexpected: individuals treated with GLP-1 medications appear to e

W hat does the latest human research really tell us about metabolic health and cognitive aging? For decades, the prevention of cognitive decline has focused almost entirely on the brain itself. Alzheimer’s disease and related dementias were framed as isolated neurological conditions driven by amyloid plaques, tau tangles, and neuronal loss. While these mechanisms remain essential, a growing body of human research suggests that this brain-only model is incomplete. Increasingly